Intervention Protocol

Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis

  1. Matthew N Hurley1,*,
  2. Andrew P Prayle2,
  3. Patrick Flume3

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 14 MAR 2012

Assessed as up-to-date: 5 FEB 2012

DOI: 10.1002/14651858.CD009730


How to Cite

Hurley MN, Prayle AP, Flume P. Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 3. Art. No.: CD009730. DOI: 10.1002/14651858.CD009730.

Author Information

  1. 1

    University of Nottingham, Department of Child Health, School of Clinical Sciences, Nottingham, UK

  2. 2

    University of Nottingham, Department of Child Health, School of Clinical Sciences & Nottingham Respiratory BRU, Nottingham, UK

  3. 3

    Medical University of South Carolina, Department of Medicine, Division of Pulmonary and Critical Care, Charleston, South Carolina, USA

*Matthew N Hurley, Department of Child Health, School of Clinical Sciences, University of Nottingham, E Floor East Block, Queens Medical Centre, Derby Road, Nottingham, NG7 2UH, UK. matthew.hurley@nottingham.ac.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 14 MAR 2012

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To establish if intravenous antibiotics for the treatment of pulmonary exacerbations in people with CF improve short- and long-term clinical outcomes.